CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-11 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | −9,000 | 0 | ||
| 2025-03-11 | KASINGER JAMES R. General Counsel and Secretary | Sale | −2,850 | $42.42 | $121K | 77,530 |
| 2025-03-11 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +2,250 | 79,780 | ||
| 2025-03-11 | KASINGER JAMES R. General Counsel and Secretary | Option exercise · Restricted Stock Units | −2,250 | 0 | ||
| 2025-03-11 | Bruno Julianne Chief Operating Officer | Sale | −1,198 | $42.42 | $51K | 8,263 |
| 2025-03-11 | Bruno Julianne Chief Operating Officer | Option exercise | +435 | 8,698 | ||
| 2025-03-11 | Bruno Julianne Chief Operating Officer | Option exercise · Restricted Stock Units | −435 | 0 | ||
| 2025-03-10 | Kulkarni Samarth Chief Executive Officer | Option exercise | +19,250 | 190,863 | ||
| 2025-03-10 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | −19,250 | 38,500 | ||
| 2025-03-10 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +5,500 | 80,380 | ||
| 2025-03-10 | KASINGER JAMES R. General Counsel and Secretary | Option exercise · Restricted Stock Units | −5,500 | 11,000 | ||
| 2025-03-10 | Bruno Julianne Chief Operating Officer | Option exercise | +2,399 | 9,461 | ||
| 2025-03-10 | Bruno Julianne Chief Operating Officer | Option exercise · Restricted Stock Units | −2,399 | 4,796 | ||
| 2025-02-26 | Greene John Director | Purchase | +7,000 | $44.85 | $314K | 7,000 |
| 2025-02-19 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −18,360 | $55.21 | $1.0M | 171,613 |
| 2025-02-19 | Bruno Julianne Chief Operating Officer | Sale | −333 | $52.80 | $18K | 7,062 |
| 2025-02-19 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,947 | $52.80 | $103K | 74,880 |
| 2025-02-19 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −6,928 | $52.80 | $366K | 189,973 |
| 2025-02-18 | Bruno Julianne Chief Operating Officer | Option exercise | +650 | 7,395 | ||
| 2025-02-18 | Bruno Julianne Chief Operating Officer | Option exercise · Restricted Stock Units | −650 | 650 |
Page 10 of 46 · 910 trades